×
For best experience we recommend to activate Javascript in your browser.
RBBP7 antibody
RBBP7
Reactivity: Human, Mouse, Rat
WB, IHC, IF, IC
Host: Rabbit
Polyclonal
unconjugated
Product Details anti-RBBP7 Antibody
(hide)
Target
See all RBBP7 Antibodies
RBBP7
(Retinoblastoma Binding Protein 7 (RBBP7))
Reactivity
All reactivities for RBBP7 antibodies
Human, Mouse, Rat
Host
All hosts for RBBP7 antibodies
Rabbit
Clonality
All clonalities for RBBP7 antibodies
Polyclonal
Conjugate
All conjugates for RBBP7 antibodies
This RBBP7 antibody is un-conjugated
Application
All applications for RBBP7 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunochromatography (IC)
Specificity
Recognizes endogenous levels of RbAp46 protein.
Characteristics
Rabbit polyclonal antibody to RbAp46
Purification
The antibody was purified by immunogen affinity chromatography.
Immunogen
Recombinant full length protein of human RbAp46
Top Product
Discover our top product RBBP7 Primary Antibody
Alternatives
(show)
Application Details
(hide)
Application Notes
WB (1:500 - 1:2000), IH (1:50 - 1:200), IF/IC (1:50 - 1:200)
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Liquid in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3, 30 % glycerol, and 0.01 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
Expiry Date
12 months
Target Details for RBBP7
(hide)
Target
RBBP7
(Retinoblastoma Binding Protein 7 (RBBP7))
Alternative Name
RbAp46 (RBBP7 Products )
Background
RBAP46, Histone-binding protein RBBP7, Histone acetyltransferase type B subunit 2, Nucleosome-remodeling factor subunit RBAP46, Retinoblastoma-binding protein 7, RBBP-7, Retinoblastoma-binding protein p46
Gene ID
5931, 245688, 83712
UniProt
Q16576 , Q60973 , Q71UF4
Recently viewed
(hide)
Chat with us , powered by LiveChat